Purchase Order N6311621P0567
Award Date 8/30/21
Potential Completion Date 12/1/21
Potential Value $98K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an...
- This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
- This is a $41,137.76 firm fixed price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract is for the delivery of Illumina RNA Prep kits and reagents to support laboratories at the Naval Health Research Center (NHRC) in San Diego, California. The award was made on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), with deliveries scheduled on four dates between...
- The Bureau of Medicine and Surgery (BUMED) awarded a $12,990.38 firm fixed-price purchase order to Illumina, Inc. on November 11, 2025, for specialized molecular biology reagents and diagnostic kits with an ultimate completion date of February 6, 2026. The contract covers a MiSeq Reagent Nano Kit V2 (300-cycles) and an Illumina Respiratory Virus Enrichment Kit Set A, both critical components for next-generation sequencing applications. Performance will take place in San Diego, California,...
- This federal contract award to Illumina, Inc. is a purchase order (PO) for a MiSeq System, a genomic sequencing instrument, valued at $95,931.00. The award was made by the U.S. Navy Bureau of Medicine and Surgery (BUMED) and is not associated with a set-aside program. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing these products and related services to various federal agencies, including the National Institutes of Health (NIH),...
- This federal contract award, valued at $89,232.71, was issued by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc. Illumina, a manufacturer of genomic sequencing instruments and reagents, is providing health check services for BUMED's MiSeq and NextSeq 500 sequencing systems under this firm fixed price purchase order. The award is not associated with a larger contract vehicle and does not have a set-aside designation. Illumina has previously supported genomic research and...
- This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- This is a firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $89,348 contract is for Illumina's RNA Prep with Enrichment, DNA/RNA Universal Dual Indexes, Respiratory Virus Oligo Panel, and MiSeq reagent kits to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is part of an...
- This is a sole-source federal contract award from the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $76,243.05 firm fixed-price purchase order is for Illumina's RNA Prep with Enrichment kits, IDT for Illumina DNA/RNA UD Indexes, Respiratory Virus Oligo Panel v2, and MiSeq Reagent Kits to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research...